$48.96−2.45 (−4.77%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
Celanese (CE) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 7.1% in FY25, net margin −12.1%.
The four lines that matter · FY21–FY25
Revenue ($M)▼7.1%
9,544.0
FY21→FY25CAGR +2.8%/yr
Net income ($M)▲25.0%
−1,151.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▲51.2%
803.0
FY21→FY25CAGR −11.2%/yr
Diluted EPS▲24.6%
−10.64
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−2.3%
112.1mn → 109.5mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$343.0M
−21.1% YoY in FY25 · 3.6% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-12¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 31.4% → 20.5%. Net margin -12.1% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 9,849.0 | 9,544.0 | 10,268.0 | 10,926.0 | 9,673.0 | 8,537.0 | ▼7.1% | +2.8% |
Cost of revenue | 7,801.0 | 7,592.0 | 7,932.0 | 8,343.0 | 7,293.0 | 5,855.0 | ▼4.3% | +6.7% |
Gross profit | 2,048.0 | 1,952.0 | 2,336.0 | 2,583.0 | 2,380.0 | 2,682.0 | ▼16.4% | −7.6% |
Research & development | 118.0 | 125.0 | 130.0 | 146.0 | 112.0 | 86.0 | ▼3.8% | +9.8% |
Selling, general & admin | 948.0 | 899.0 | 1,033.0 | 1,077.0 | 824.0 | 633.0 | ▼13.0% | +9.2% |
Total operating expenses | 1,267.0 | 2,738.0 | 3,056.0 | 918.0 | 1,007.0 | 736.0 | ▼10.4% | +38.9% |
Operating incomefeeds ROC rank | 781.0 | −786.0 | −720.0 | 1,665.0 | 1,378.0 | 1,946.0 | ▼9.2% | — |
Other income, net | −451.0 | −434.0 | −299.0 | −504.0 | 43.0 | 302.0 | — | — |
Pretax income | 330.0 | −1,220.0 | −1,019.0 | 1,161.0 | 1,421.0 | 2,248.0 | ▼19.7% | — |
Income tax | 43.0 | −90.0 | 507.0 | −795.0 | −489.0 | 330.0 | — | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | 277.0 | −1,151.0 | −1,534.0 | 1,947.0 | 1,902.0 | 1,896.0 | ▲25.0% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 2.37 | −10.64 | −14.11 | 17.76 | 17.34 | 16.86 | ▲24.6% | — |
Diluted shares (mn) | 110.20 | 109.53 | 109.27 | 109.38 | 109.24 | 112.08 | ▲0.2% | −0.6% |
| Margins | ||||||||
Gross margin28th pct in Basic Materials | 20.8% | 20.5% | 22.8% | 23.6% | 24.6% | 31.4% | ▼2.3pp | −11.0pp |
Operating margin | 7.9% | −8.2% | −7.0% | 15.2% | 14.2% | 22.8% | ▼1.2pp | −31.0pp |
Net margin23rd pct in Basic Materials | 2.8% | −12.1% | −14.9% | 17.8% | 19.7% | 22.2% | ▲2.9pp | −34.3pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 15% vs a −34% norm for this window, likely a one-time item; see the filing.FY23 effective tax rate was −68% vs a −34% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Celanese's revenue last fiscal year?
Celanese reported revenue of $9,544.0M in fiscal 2025, down 7.1% from fiscal 2024.
What was Celanese's net income?
Celanese reported net income of −$1,151.0M in fiscal 2025, a net margin of −12.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

